Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad
Descripción del Articulo
Objective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proport...
Autores: | , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2022 |
Institución: | Colegio Médico del Perú |
Repositorio: | Acta Médica Peruana |
Lenguaje: | español |
OAI Identifier: | oai:ojs.pkp.sfu.ca:article/2336 |
Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/2336 |
Nivel de acceso: | acceso abierto |
Materia: | SARS-CoV-2 COVID-19 Risk Factors Coronavirus Infections Hospitalization Mortality Survival Peru |
id |
REVCMP_2446208211f36d8889b393d59e2b0cc8 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/2336 |
network_acronym_str |
REVCMP |
network_name_str |
Acta Médica Peruana |
repository_id_str |
. |
spelling |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La LibertadFactores de riesgo asociados a mortalidad en pacientes con neumonía por SARS-CoV-2 en un Hospital-I del Seguro Social, Perú-La LibertadArana-Calderón, César AlejandroChávez-Guevara, Sandra PaolaSARS-CoV-2COVID-19Risk FactorsCoronavirus InfectionsHospitalizationMortalitySurvivalPeruObjective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proportional hazards model was used, calculating crude and adjusted hazard ratios (HR), and the Kaplan-Meier estimator was used to evaluate the overall survival curve and for each factor. Results: Of the 158 patients, the diagnosis was confirmed in 79.11%. Nearly 70% (68.99%) were men, the global median age was 65 years (IQR: 52-77), and it was higher in deceased subjects 69 years old (IQR: 61-80 years). Little more than half of this population (53.80%) had comorbidities, such as high blood pressure (27.85%), obesity (22.78%), and diabetes mellitus (13.92%). The median duration of symptoms prior to admission was 9 days (IQR: 6-11 days). HRs were determined for oxygen saturation less than 80% on admission with 0.21 FIO2, leukocytosis with associated lymphopenia, oxygen requirement at 0.80 FIO2 on admission, and moderate-severe ARDS. Such values were 1.54, 1.98, 2.07 and 2.91, respectively. Conclusions: The development of moderate-severe ARDS on admission, leukocytosis associated with lymphopenia, less than 80% hypoxemia on admission at 0.21 FIO2, and high-flow oxygen requirement since admission with 0.80 FIO2, were the only risk factors for mortality.Objetivo: Identificar características demográficas, clínicas, laboratoriales y de tratamiento asociados a la mortalidad en pacientes hospitalizados con neumonía por SARS-CoV-2 en un Hospital I del Seguro Social del Perú de la Red La Libertad. Materiales y Metodo: Estudio de cohorte retrospectiva. Se utilizo el modelo de riesgos proporcionales de Cox calculándose los cocientes de riesgo instantáneos (HR) crudos y ajustados, y el estimador de Kaplan-Meier para evaluar la curva de supervivencia general y con cada factor. Resultados: De los 158 pacientes se confirmó el diagnostico en 79,11%. El 68,99% fueron hombres, la mediana de la edad global fue de 65 años (RIC:52-77), siendo mayor en los fallecidos con 69 años (RIC:61-80 años). El 53,80% tenían comorbilidad, siendo estas la HTA (27,85%), obesidad (22,78%) y diabetes mellitus (13,92%). La mediana de duración de síntomas previo al ingreso fue de 9 días (RIC:6-11 días). Se determinó los HR para la saturación de oxigeno menor de 80% a su ingreso a un FIO2 del 0,21, la leucocitosis con linfopenia asociada, el requerimiento de oxígeno a un FIO2 del 0,80 a su ingreso y el SDRA moderado-severo, los cuales fueron de 1.54, 1.98, 2.07 y 2.91, respectivamente. Conclusiones: El desarrollo de un SDRA moderado-severo a su ingreso, la leucocitosis asociada con linfopenia, la hipoxemia de ingreso menor a 80% a un FIO2 del 0,21, y el requerimiento de oxígeno a alto flujo desde su ingreso con un FIO2 del 0,80, fueron los únicos factores de riesgo de mortalidad encontrados.Colegio Médico del Perú2022-08-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/233610.35663/amp.2022.392.2336ACTA MEDICA PERUANA; Vol 39 No 2 (2022): April - JuneACTA MEDICA PERUANA; Vol. 39 Núm. 2 (2022): Abril - Junio1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2336/1460Copyright (c) 2022 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/23362023-07-06T05:49:26Z |
dc.title.none.fl_str_mv |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad Factores de riesgo asociados a mortalidad en pacientes con neumonía por SARS-CoV-2 en un Hospital-I del Seguro Social, Perú-La Libertad |
title |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
spellingShingle |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad Arana-Calderón, César Alejandro SARS-CoV-2 COVID-19 Risk Factors Coronavirus Infections Hospitalization Mortality Survival Peru |
title_short |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
title_full |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
title_fullStr |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
title_full_unstemmed |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
title_sort |
Risk factors associated with mortality in patients with SARS-CoV-2 pneumonia in a Level I Social Security Hospital, Peru-La Libertad |
dc.creator.none.fl_str_mv |
Arana-Calderón, César Alejandro Chávez-Guevara, Sandra Paola |
author |
Arana-Calderón, César Alejandro |
author_facet |
Arana-Calderón, César Alejandro Chávez-Guevara, Sandra Paola |
author_role |
author |
author2 |
Chávez-Guevara, Sandra Paola |
author2_role |
author |
dc.subject.none.fl_str_mv |
SARS-CoV-2 COVID-19 Risk Factors Coronavirus Infections Hospitalization Mortality Survival Peru |
topic |
SARS-CoV-2 COVID-19 Risk Factors Coronavirus Infections Hospitalization Mortality Survival Peru |
description |
Objective: To identify demographic, clinical, laboratory and treatment characteristics associated with mortality in hospitalized patients with SARS-CoV-2 pneumonia in a Level I Hospital of Peruvian Social Security, at La Libertad Network. Materials and Method: Retrospective cohort study. Cox proportional hazards model was used, calculating crude and adjusted hazard ratios (HR), and the Kaplan-Meier estimator was used to evaluate the overall survival curve and for each factor. Results: Of the 158 patients, the diagnosis was confirmed in 79.11%. Nearly 70% (68.99%) were men, the global median age was 65 years (IQR: 52-77), and it was higher in deceased subjects 69 years old (IQR: 61-80 years). Little more than half of this population (53.80%) had comorbidities, such as high blood pressure (27.85%), obesity (22.78%), and diabetes mellitus (13.92%). The median duration of symptoms prior to admission was 9 days (IQR: 6-11 days). HRs were determined for oxygen saturation less than 80% on admission with 0.21 FIO2, leukocytosis with associated lymphopenia, oxygen requirement at 0.80 FIO2 on admission, and moderate-severe ARDS. Such values were 1.54, 1.98, 2.07 and 2.91, respectively. Conclusions: The development of moderate-severe ARDS on admission, leukocytosis associated with lymphopenia, less than 80% hypoxemia on admission at 0.21 FIO2, and high-flow oxygen requirement since admission with 0.80 FIO2, were the only risk factors for mortality. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-08-13 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2336 10.35663/amp.2022.392.2336 |
url |
https://amp.cmp.org.pe/index.php/AMP/article/view/2336 |
identifier_str_mv |
10.35663/amp.2022.392.2336 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2336/1460 |
dc.rights.none.fl_str_mv |
Copyright (c) 2022 ACTA MEDICA PERUANA info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 ACTA MEDICA PERUANA |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
publisher.none.fl_str_mv |
Colegio Médico del Perú |
dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol 39 No 2 (2022): April - June ACTA MEDICA PERUANA; Vol. 39 Núm. 2 (2022): Abril - Junio 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
instname_str |
Colegio Médico del Perú |
instacron_str |
CMP |
institution |
CMP |
reponame_str |
Acta Médica Peruana |
collection |
Acta Médica Peruana |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1816075111830126592 |
score |
13.940932 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).